Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.8723
-0.1227 (-12.33%)
At close: Jun 5, 2026, 4:00 PM EDT
0.8630
-0.0093 (-1.07%)
After-hours: Jun 5, 2026, 7:26 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $25.25 million as of June 5, 2026. Its market cap has decreased by -54.75% in one year.
Market Cap
25.25M
Enterprise Value
93.79M
1-Year Change
-54.75%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $25.25M, a decrease of -92.83%. That is a compound annual growth rate of -32.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 28.80M | -8.89% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 30.44M |
| Quantum BioPharma | 30.42M |
| Lite Strategy | 29.40M |
| IGC Pharma | 28.92M |
| CervoMed | 28.89M |
| Tvardi Therapeutics | 28.61M |
| Barinthus Biotherapeutics | 28.19M |
| BriaCell Therapeutics | 28.10M |